Authors:
Mikhaildis, DP
Wierzbicki, AS
Reynolds, TM
Citation: Dp. Mikhaildis et al., Is a mechanical or a metabolic approach superior in the treatment of coronary disease? Results of the atorvastatin versus revascularization (AVERT) trial, EUR HEART J, 22(11), 2001, pp. 972-972
Citation: Tm. Reynolds, Down's syndrome screening: a controversial test, with more controversy to come! The author replies, J CLIN PATH, 54(7), 2001, pp. 573-573
Authors:
Wierzbicki, AS
Reynolds, TM
Gill, K
Alg, S
Crook, MA
Citation: As. Wierzbicki et al., A comparison of algorithms for initiation of lipid lowering therapy in primary prevention of coronary heart disease, J CARD RISK, 7(1), 2000, pp. 63-71
Citation: Tm. Reynolds et As. Wierzbicki, Survival and reduction in mortality from breast cancer - Improvements in survival may be an illusion, BR MED J, 321(7274), 2000, pp. 1471-1471
Citation: Tm. Reynolds et As. Wierzbicki, Survival and reduction in mortality from breast cancer - Diagnostic practice in the United States is different, BR MED J, 321(7274), 2000, pp. 1471-1471
Authors:
Bischoff, WE
Reynolds, TM
Sessler, CN
Edmond, MB
Wenzel, RP
Citation: We. Bischoff et al., Handwashing compliance by health care workers - The impact of introducing an accessible, alcohol-based hand antiseptic, ARCH IN MED, 160(7), 2000, pp. 1017-1021
Citation: As. Wierzbicki et Tm. Reynolds, Cholesterol: How low is low enough? Doctors have been slow in getting evidence on lowering cholesterol into practice, BR MED J, 318(7182), 1999, pp. 539-539
Authors:
Bischoff, WE
Reynolds, TM
Hall, GO
Wenzel, RP
Edmond, MB
Citation: We. Bischoff et al., Molecular epidemiology of vancomycin-resistant Enterococcus faecium in a large urban hospital over a 5-year period, J CLIN MICR, 37(12), 1999, pp. 3912-3916